Press Releases Waypoint AI Raises $3.1M Pre-Seed Round; Deploys first AI Customer Support Engineer for industry leaders including ClickHouse and Kpler.

Waypoint AI Raises $3.1M Pre-Seed Round; Deploys first AI Customer Support Engineer for industry leaders including ClickHouse and Kpler.

The addition of tezepelumab to standard treatment allowed half the adults with severe asthma to discontinue their use of oral corticosteroids (OCS) after 1 year, according to new data from nearly ...

Tezepelumab demonstrated clinically relevant benefits in specific inflammatory subtypes of COPD - an historically underserved market.

Tezepelumab (Tezspire) has shown significant clinical benefits in adults with severe chronic rhinosinusitis with nasal polyps (CRSwNP), including marked reductions in nasal congestion and polyp ...

Waypoint Residential advances a mixed-use development with 286 apartments on surface parking near the Tri-Rail station in Oakland Park’s Cypress Creek.

Tezepelumab was associated with significantly greater reductions in nasal polyp size and nasal congestion severity compared with placebo among adults with severe, uncontrolled chronic rhinosinusitis ...

Dozens of people gathered at Bronstein Park in Manchester on Friday for Waypoint's 11th annual "SleepOut," an event meant to raise awareness about youth homelessness in New Hampshire.

“The Waypoint results highlight the potential for tezepelumab as a new treatment option for patients with CRSwNP that has demonstrated rapid and sustained improvements in disease symptoms and ...

Full results from the positive phase III WAYPOINT trial showed AstraZeneca and Amgen’s Tezspire (tezepelumab) significantly reduced nasal polyp severity, the need for subsequent surgery, and systemic ...

Amgen and AstraZeneca's Tezspire showed significant reductions in nasal polyp severity, congestion, and surgery need in CRSwNP patients in the Phase 3 WAYPOINT trial.

About the Phase 3 WAYPOINT Trial WAYPOINT is a double-blind, multi-center, randomized, placebo-controlled, parallel group trial designed to evaluate the efficacy and safety of tezepelumab in adults ...